Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Finasteride increases risk of sleep apnea and insomnia.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Ixekizumab has known and some unexpected side effects.

Finasteride use may increase suicidality risk, especially in young men.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Reporter characteristics affect detection of hair loss from cancer therapy.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Topical finasteride may be safer than oral finasteride, but more research is needed.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Family caregivers take longer to fall asleep and have more sleep disturbances, which may contribute to their health problems.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Finasteride use is linked to a higher risk of obstructive sleep apnea.

Finasteride use is linked to a higher risk of obstructive sleep apnea.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.